Jean‐Pierre Bergerat

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

<i>Aspergillus</i>Galactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer Patients

Raoul Herbrecht, Valérie Letscher‐Bru, Corina Oprea et al. · Journal of Clinical Oncology · 2002 · 391 citations

Life Sciences, Microbiology, Oncology +16

Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis

Yasmine Nivoix, Michel Velten, Valérie Letscher‐Bru et al. · Clinical Infectious Diseases · 2008 · 341 citations · Full text

Medicine, Infectious Diseases, Microbiology +16

Role of Cationic Channel TRPV2 in Promoting Prostate Cancer Migration and Progression to Androgen Resistance

Michaël Monet, V’yacheslav Lehen’kyi, Florian Gackière et al. · Cancer Research · 2010 · 224 citations · Full text

Medicine, Molecular Biology, Oncology +17

Two metachronous tumors in the radiotherapy fields of a patient with Li‐Fraumeni syndrome

Jean‐Marc Limacher, Thierry Frébourg, Shanti Natarajan‐Amé et al. · International Journal of Cancer · 2001 · 146 citations

Medicine, Oncology, Radiation Oncology +15